The UK-US deal on pharmaceuticals is now finalised, an important step for UK life sciences. Read our short statement ⤵️
Sobre nosotros
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia
- Sitio web
-
http://www.gsk.com
Enlace externo para GSK
- Sector
- Fabricación de productos farmacéuticos
- Tamaño de la empresa
- Más de 10.001 empleados
- Sede
- London, England
- Tipo
- Empresa pública
- Especialidades
- Pharmaceutical products y Vaccines
Ubicaciones
Empleados en GSK
Actualizaciones
-
Colorectal cancer is a global challenge on the rise – even among young adults. In his latest article, Ali Çimen, SVP, Head of Global Medical Affairs Oncology & Head of GPS Oncology (a.i.), explores this urgent reality and GSK's dedication to transforming cancer care through collaboration and scientific innovation – always inspired by patient stories. From improved screening and biomarker testing to innovations in treatment, we're striving for a future where every patient has the chance at a longer, fuller life. Read Ali's article and join the conversation: https://gsk.to/3Obz3vl #ColorectalCancerAwarenessMonth
-
#News for #investors and #media: Today we are announcing that our potential first-in-class treatment for chronic hepatitis B (CHB) has been accepted for regulatory review in China. This marks an important step towards addressing the global burden of CHB. We are committed to reshaping the treatment landscape for people living with CHB. Learn more: https://gsk.to/4rYo9XT
-
#News for #Media and #Investors: China’s National Medical Products Administration (NMPA) has approved our new therapy for the treatment of severe asthma. For more information, visit: https://gsk.to/4uXPfRt
-
#News for #investors and #media: Today we are announcing that our potential first-in-class treatment for chronic hepatitis B has been accepted for regulatory review by the EMA. Learn more: https://gsk.to/47W23xQ
-
Today, on #WorldTBDay, we’re reflecting on the significant challenge tuberculosis (TB) continues to pose, affecting over 10 million people annually and putting significant strain on communities and healthcare systems. Our science is at the forefront of efforts to help tackle TB. By working with partners to discover new ways to prevent and treat the disease, we’re fuelling innovation across our entire pipeline, particularly in tackling drug-resistant forms of TB. Together, we’re aiming to positively impact the health of millions of people worldwide.
-
#News for #Investors and #Media: Today, we announced that the Ministry of Health, Labour and Welfare in Japan has granted Orphan Drug Designation (ODD) to an investigational antibody-drug conjugate in our oncology pipeline. Learn more: https://gsk.to/4sWGpBz
-
Manufacturing the medicines and vaccines patients rely on depends on a secure water supply. That’s why we’re working to protect and restore water resources where we operate. This World Water Day marks one year of our five-year partnership with WWF-UK. Together, we’re restoring freshwater resources in regions where water is scarce and where we have manufacturing sites. We’re now expanding this work into Algeria, building on our ongoing efforts in India and Pakistan. By strengthening water resilience, we’re helping to build supply chain resilience and safeguard medicine production. Want to learn more about our partnership? https://lnkd.in/e439V4bm
-
#News for #investors and #media: Today, we are announcing that one of our liver medicines has been approved by the US Food and Drug Administration (FDA). Find out more: https://gsk.to/4bti7JT #GSK #AheadTogether
-
We're excited to announce our involvement in the new national Respiratory Transformation Partnership (RTP). This ambitious coalition brings together the Health Innovation Network, NHS systems, leading industry partners, the Office for Life Sciences, NHS England, professional bodies and the third sector. Our collaboration involves providing funding to support the co development and delivery of locally led initiatives focused on addressing unmet needs in respiratory care, accelerating diagnosis, improving treatment pathways and ultimately transforming the lives of thousands of people affected by asthma and lung disease. We’re committed to leveraging science and technology to get ahead of respiratory diseases, and this partnership is a significant step towards delivering better prevention and treatment options for patients. Learn more https://gsk.to/4uCKb4I
-